Inhibition of N-methyl-D-aspartate-activated current by bis(7)-tacrine in HEK-293 cells expressing NR1/NR2A or NR1/NR2B receptors

Abstract

In normal rat forebrain, the NR1/NR2A and NR1/NR2B dimmers are the main constitutional forms of NMDA receptors. The present study was carried out to determine the functional properties of the heteromeric NMDA receptor subunits and their inhibition by bis(7)-tacrine (B7T). Rat NR1, NR2A and NR2B cDNAs were transfected into human embryonic kidney 293 cells (HEK-293). The inhibition of NMDA-activated currents by B7T was detected in HEK-293 cell expressing NR1/NR2A or NR1/NR2B receptors by using whole-cell patch-clamp techniques. The results showed that in HEK-293 cells expressing NR1/NR2A receptor, 1 μmol/L B7T inhibited 30 μmol/L NMDA- and 1000 μmol/L NMDA-activated steady-state currents by 46% and 40%, respectively (P>0.05; n=5), suggesting that the inhibition of B7T on NR1/NR2A receptor doesn’t depend on NMDA concentration, which is consistent with a non-competitive mechanism of inhibition. But for the NR1/NR2B receptor, 1 μmol/L B7T inhibited 30 μmol/L NMDA- and 1000 μmol/L NMDA-activated steady-state currents by 61% and 13%, respectively (P<0.05; n=6), showing that B7T appears to be competitive with NMDA. In addition, simultaneous application of 1 μmol/L B7T and 1000 μmol/L NMDA produced a moderate inhibition of peak NMDA-activated current, followed by a gradual decline of the current to a steady state. However, the gradual onset of inhibition produced by B7T applied simultaneously with NMDA was eliminated when B7T was given 5 s before NMDA. These results suggested that B7T inhibition of NMDA current mediated by NR1/NR2B receptor was slow onset, and it did not depend on the presence of the agonist. With holding potentials ranging from −50 to +50 mV, the B7T inhibition rate of NMDA currents didn’t change significantly, and neither did the reversal potential. We are led to conclude that the NR1/NR2B recombinant receptor can serve as a very useful model for studying the molecular mechanism of NMDA receptor inhibition by B7T.

Keywords

bis(7)-tacrine / N-methyl-D-aspartic acid / NR1/NR2A / NR1/NR2B

References

[1] HabernyK.A., PauleM.G., ScalletA.C., et al.. Ontogeny of the N-methyl-D-aspartate (NMDA) receptor system and susceptibility to neurotoxicity. Toxicol Sci, 2002, 68(1): 9-17

[2] MonaghanD.T., BridgesR.J., CotmanC.W.. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol, 1989, 29: 365-402

[3] TaiK.K., BlondelleS.E., OstreshJ.M., et al.. An N-methyl-D-aspartate receptor channel blocker with neuroprotective activity. Proc Natl Acad Sci USA, 2001, 98(6): 3519-3524

[4] UlbrichM.H., IsacoffE.Y.. Rules of engagement for NMDA receptor subunits. Proc Natl Acad Sci USA, 2008, 105(37): 14 163-14 168

[5] PaolettiP., NeytonJ.. NMDA receptor subunits: function and pharmacology. Curr Opin Pharmacol, 2007, 7(1): 39-47

[6] LiW., MakM., JiangH., et al.. Novel anti-Alzheimer’s dimer Bis(7)-cognitin: cellular and molecular mechanisms of neuroprotection through multiple targets. Neurotherapeutics, 2009, 6(1): 187-201

[7] WuD.C., XiaoX.Q., NgA.K., et al.. Protection against ischemic injury in primary cultured mouse astrocytes by bis(7)-tacrine, a novel acetylcholinesterase inhibitor. Neurosci Lett, 2000, 288(2): 95-98

[8] XiaoX.Q., LeeN.T., CarlierP.R., et al.. Bis(7)-tacrine, a promising anti-Alzheimer’s agent, reduces hydrogen peroxide-induced injury in rat pheochromocytoma cells: comparison with tacrine. Neurosci Lett, 2000, 290(3): 197-200

[9] LiC., WangH., XueH., et al.. Bis(7)-tacrine, a novel dimeric AchE inhibitor, is a potent GABA(A) receptor antagonist. NeuroReport, 1999, 10(4): 795-800

[10] ZhouL., LiuY.W., PeoplesR.W., et al.. Mechanism of bis(7)-tacrine inhibition of GABA-activated current in cultured rat hippocampal neurons. Neuropharmacology, 2009, 57(1): 33-40

[11] LiuY.W., LuoJ.L., RenH., et al.. Inhibition of NMDA-gated ion channels by bis(7)-tacrine: whole-cell and single-channel studies. Neuropharmacology, 2008, 54(7): 1086-1094

[12] LiuY.W., LiC.Y., LuoJ.L., et al.. Bis(7)-tacrine prevents glutamate-induced excitotoxicity more potently than memantine by selectively inhibiting NMDA receptors. Biochem Biophys Res Commun, 2008, 369(4): 1007-1011

[13] RaoA., CraigA.M.. Activity regulates the synaptic localization of the NMDA receptor in hippocampal neurons. Neuron, 1997, 19(4): 801-812

[14] RenH., SalousA.K., PaulJ.M., et al.. Mutations at F637 in the NMDA receptor NR2A subunit M3 domain influence agonist potency, ion channel gating and alcohol action. Br J Pharmacol, 2007, 151(6): 749-757

[15] ChenN., LuoT., WellingtonC., et al.. Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin. J Neurochem, 1999, 72(5): 1890-1898

[16] ChenN., LuoT., RaymondL.A.. Subtype-dependence of NMDA receptor channel open probability. J Neurosci, 1999, 19(16): 6844-6854

[17] LiW., PiR., ChanH.H., et al.. Novel dimeric acetylcholinesterase inhibitor bis7-tacrine, but not donepezil, prevents glutamate-induced neuronal apoptosis by blocking N-methyl-D-aspartate receptors. J Biol Chem, 2005, 280(18): 18 179-18 188

[18] LiW., XueJ., NiuC., et al.. Synergistic neuroprotection by bis(7)-tacrine via concurrent blockade of N-methyl-Daspartate receptors and neuronal nitric-oxide synthase. Mol Pharmacol, 2007, 71(5): 1258-1267

[19] FuH., LiW., LaoY., et al.. Bis(7)-tacrine attenuates beta amyloid-induced neuronal apoptosis by regulating L-type calcium channels. J Neurochem, 2006, 98(5): 1400-1410

[20] XiaoX.Q., LeeN.T., CarlierP.R., et al.. Bis(7)-tacrine, a promising anti-Alzheimer’s agent, reduces hydrogen peroxide-induced injury in rat pheochromocytoma cells: comparison with tacrine. Neurosci Lett, 2000, 290(3): 197-200

[21] ElfversonM., LindeA.M., Le GrevèsP., et al.. Neurosteroids allosterically modulate the ion pore of the NMDA receptor consisting of NR1/NR2B but not NR1/NR2A. Biochem Biophys Res Commun, 2008, 372(2): 305-308

[22] ChenN., MoshaverA., RaymondL.A.. Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition. Mol Pharmacol, 1997, 51(6): 1015-1023

[23] BresinkI., BenkeT.A., CollettV.J., et al.. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells. Br J Pharmacol, 1996, 119(2): 195-204

[24] AndersD.L., BlevinsT., SuttonG., et al.. Fyn tyrosine kinase reduces the ethanol inhibition of recombinant NR1/NR2A but not NR1/NR2B NMDA receptors expressed in HEK 293 cells. J Neurochem, 1999, 72(4): 1389-1393